Bizalimogene ralaplasmid Uses, Dosage, Side Effects and more
Bizalimogene ralaplasmid is under investigation in clinical trial NCT03499795 (VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 And/or HPV-18 Related Anal or Anal/peri-anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2).
| Trade Name | Bizalimogene ralaplasmid |
| Generic | Bizalimogene ralaplasmid |
| Bizalimogene ralaplasmid Other Names | Bizalimogene ralaplasmid |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
